Brief: Lumos Diagnostics Files Appeal To U.S. FDA On Decision Not To Grant Clearance To Market Febridx

Lumos Diagnostics Holdings

08/08/2022 02:31

Aug 8 (Reuters) - Lumos Diagnostics Holdings Ltd  LDX.AX :
    * FILED AN APPEAL TO US FDA REGARDING ITS DECISION NOT TO
GRANT
CLEARANCE TO MARKET FEBRIDX IN US
    * CONTINUING TO PURSUE OPTIONS TO SECURE REGULATORY
CLEARANCE TO
MARKET FEBRIDX IN US
    * OUTCOME OF THIS APPEAL APPLICATION IS EXPECTED IN Q4
CY2022

Source text for Eikon:  ID:nASX8qpkZy 
Further company coverage:  LDX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))